Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis D Leal

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Gastrointestinal Oncology|November 18, 2021
Neoadjuvant treatment of localized pancreatic adenocarcinomaAlexis D Leal, Wells A Messersmith, Christopher H Lieu
Expert Opinion on Investigational Drugs|October 26, 2018
Antibody drug conjugates under investigation in phase I and phase II clinical trials for gastrointestinal cancerAlexis D Leal, Anuradha Krishnamurthy, Lia Head, et al.
Leukemia & Lymphoma|July 19, 2017
Variability of performance status assessment between patients with hematologic malignancies and their physiciansAlexis D Leal, Cristine Allmer, Matthew J Maurer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2014
An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapyLivia T Hegerova, Alexis D Leal, Darryl C Grendahl, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 13, 2013
Antiemetic prescribing practices using a computerized physician order entry systemKunal C Kadakia, Alexis D Leal, Drew K Seisler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2018
Ten-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic ChemotherapyCiara C O'Sullivan, Holly K Van Houten, Lindsey R Sangaralingham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 5, 2025
Real-World Analysis of Irinotecan With or Without Fluorouracil in the Second-Line Treatment of Metastatic Colorectal CancerRobert W Lentz, Junxiao Hu, Hannah Robinson, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2023
A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2023
Correction to: A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2015
Hormonal and Reproductive Factors and Risk of Myeloproliferative Neoplasms in Postmenopausal WomenAlexis D Leal, Carrie A Thompson, Alice H Wang, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Gastrointestinal Oncology|November 18, 2021
Neoadjuvant treatment of localized pancreatic adenocarcinomaAlexis D Leal, Wells A Messersmith, Christopher H Lieu
Expert Opinion on Investigational Drugs|October 26, 2018
Antibody drug conjugates under investigation in phase I and phase II clinical trials for gastrointestinal cancerAlexis D Leal, Anuradha Krishnamurthy, Lia Head, et al.
Leukemia & Lymphoma|July 19, 2017
Variability of performance status assessment between patients with hematologic malignancies and their physiciansAlexis D Leal, Cristine Allmer, Matthew J Maurer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2014
An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapyLivia T Hegerova, Alexis D Leal, Darryl C Grendahl, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 13, 2013
Antiemetic prescribing practices using a computerized physician order entry systemKunal C Kadakia, Alexis D Leal, Drew K Seisler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2018
Ten-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic ChemotherapyCiara C O'Sullivan, Holly K Van Houten, Lindsey R Sangaralingham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 5, 2025
Real-World Analysis of Irinotecan With or Without Fluorouracil in the Second-Line Treatment of Metastatic Colorectal CancerRobert W Lentz, Junxiao Hu, Hannah Robinson, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2023
A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2023
Correction to: A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2015
Hormonal and Reproductive Factors and Risk of Myeloproliferative Neoplasms in Postmenopausal WomenAlexis D Leal, Carrie A Thompson, Alice H Wang, et al.
Pageof 3